Aminophenazone

DB01424ApprovedWithdrawnSmall molecule

Aminophenazone is an analgesic drug used to treat acute migraine attacks in combination with ergotamine and caffeine. Aminophenazone is a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties that carries a risk of agranulocytosis.

Chemical structure of Aminophenazone
Mechanism
Curator reviewed
Primary indication
Formerly widely used as an antipyretic and analgesic in rheumatism, neuritis, and common colds.Curator reviewed · 1 structured indication
Formula / weight
C13H17N3O · 231.2936 g/mol (avg)
Also known as
(Dimethylamino)phenazone · 4-Dimethylaminoantipyrine · 4-Dimethylaminophenazone · Aminofenazone · Aminopyrine
Code names
NSC-4993

Resolves to

Structure
InChIKeyRMMXTBMQSGEXHJ-UHFFFAOYSA-NSMILESCN(C)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1
Transporters

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1,847Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
17ContraindicationsEach with its own population and attribute set
Sign in
3Marketed productsAcross 2 countries and 2 labellers
Sign in
3ATC codesIncluding every combination product, plus 22 drug categories
Sign in
28+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Aminophenazone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account